Grants per year
Search results
-
Active
Assessing the Risk of SARS-CoV-2 Remdesivir Resistance
Hultquist, J. F., Ison, M. G., Lorenzo Redondo, R. & Ozer, E. A.
National Institute of Allergy and Infectious Diseases
7/1/21 → 6/30/23
Project: Research project
-
Protocol No. P10934-CMVPS-CSP-01: Clinical Performance of the Aptima® CMV Quant Assay on the Panther® System
5/2/19 → 5/2/22
Project: Research project
-
Prot. CP40617 - A Phase III, Multicenter, Randomized, Double-Blind, Active-Controlled Study to Assess the Efficacy and Safety of Baloxavir Marboxil in Combination with a Neuraminidase Inhibitor versus a Neuraminidase Inhibitor Alone in Hospitalized Patien
Syneos Health, Inc., Genentech, Inc.
2/22/19 → 2/22/22
Project: Research project
-
Assessing SARS-CoV-2 Variant Evolution in Patients
Wunderink, R. G., Achenbach, C. J., Hultquist, J. F., Ison, M. G., Lorenzo Redondo, R., Ozer, E. A., Qi, C., Scholtens, D. M., Amaral, L. A. N., Hauser, A. R. & Misharin, A.
National Institute of Allergy and Infectious Diseases
1/17/18 → 12/31/22
Project: Research project
-
AIC316-03-II-01 A Randomized, Open Label, Multi-Center, Comparative Trial, to Assess the Efficacy and Safety of Pritelivir Versus Foscarnet for the Treatment of Acyclovir-Resistant Mucocutaneous HSV Infections in Immunocompromised Adults (PRIOH-1)
Medpace, Inc., AiCuris Anti-infective Cures GmbH
12/1/17 → 12/1/22
Project: Research project
-
Fixed Price Patient Care Costs
National Institute of Allergy and Infectious Diseases
7/1/16 → 4/3/22
Project: Research project
-
Phase II Multi-Center, Prospective, Randomized, Double-Blind Study of Nitazoxanide in Acute and Chronic Norovirus in Hematpoietic Stem Cell and Solid Organ Transplant Recipients
Ison, M. G., Angarone, M. P. & Zhao, L.
National Institute of Allergy and Infectious Diseases
7/1/16 → 4/3/22
Project: Research project
-
-
Finished
-
ACTIV-1 IM: Randomized Master Protocol for Immune Modulators for Treating COVID-19
Duke University, Biomedical Advanced Research and Development Authority
8/17/20 → 8/16/21
Project: Research project
-
Prot. Number IA-001: A Randomized, Double-Blind, Placebo-Controlled Dose Ranging Study Evaluating the Safety, Pharmacokinetics and Clinical Benefit of FLU-IGIV in Hospitalized Patients with Serious Influenza A Infection
SGS North America Inc., Cangene Corporation
12/15/17 → 12/15/20
Project: Research project
-
High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients
Vanderbilt University, National Institute of Allergy and Infectious Diseases
7/5/17 → 6/30/19
Project: Research project
-
Protocol 9766-CL-0111 - A Non-Interventional Registry Study of Systemic Antifungal Therapy in Adult Subjects with Invasive Mucormycosis or Invasive Aspergillosis Caused by a Non-fumigatus Species Protocol for Phase 4 Study of ASP9766
inVentiv Health Clinical, Astellas Pharma Global Development, Inc.
4/7/17 → 4/7/20
Project: Research project
-
PROTOCOL: SHP620-303 A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients with Cytomegalovirus (CMV) Infection
PPD Development, Shire ViroPharma Incorporated
3/24/17 → 3/24/21
Project: Research project
-
Prot #63623872FLZ2002: A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adolescent, Adult, and Elderly Hospitalized Patients W
Janssen Research & Development, LLC
1/19/16 → 8/31/18
Project: Research project
-
Protocol Number: IRC-005 A Randomized Double-Blind, Phase 3 Study Comparing the Efficacy and Safety of High-Titer versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A
Social & Scientific Systems, Inc., National Institute of Allergy and Infectious Diseases
10/16/15 → 9/30/18
Project: Research project